Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · IEX Real-Time Price · USD
1.100
-0.020 (-1.79%)
Jul 22, 2024, 9:30 AM EDT - Market open
Accelerate Diagnostics Employees
Accelerate Diagnostics had 134 employees as of December 31, 2023. The number of employees decreased by 45 or -25.14% compared to the previous year.
Employees
134
Change (1Y)
-45
Growth (1Y)
-25.14%
Revenue / Employee
$90,806
Profits / Employee
-$440,694
Market Cap
24.48M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ATI Physical Therapy | 6,000 |
Meihua International Medical Technologies Co. | 617 |
Trinity Biotech | 380 |
Beyond Air | 107 |
Femasys | 34 |
CytoMed Therapeutics | 27 |
Unity Biotechnology | 19 |
NeuroBo Pharmaceuticals | 8 |
AXDX News
- 2 months ago - Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results. - PRNewsWire
- 4 months ago - Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results - PRNewsWire
- 4 months ago - Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results. - PRNewsWire
- 6 months ago - Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement - PRNewsWire
- 6 months ago - Accelerate Diagnostics Announces Launch of Proposed Public Offering - PRNewsWire
- 7 months ago - Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results - PRNewsWire
- 8 months ago - Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper® - PRNewsWire